Radiation Therapy for Tumors Medical Services in China

Radiation oncology, or radiotherapy for malignant tumors, is a cornerstone of modern cancer management. It employs precisely targeted ionizing radiation—such as photons, electrons, protons, or brachytherapy sources—to destroy cancer cells while sparing adjacent healthy tissue. Radiotherapy may be delivered curatively (e.g., for early-stage nasopharyngeal carcinoma or prostate cancer), adjuvantly (post-surgery to eliminate microscopic residual disease), neoadjuvantly (to shrink tumors preoperatively), or palliatively (to relieve pain, bleeding, or obstruction in advanced disease). Treatment planning relies on multimodal imaging—including contrast-enhanced CT, MRI, and PET-CT—to define gross tumor volume (GTV), clinical target volume (CTV), and planning target volume (PTV)—followed by intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic body radiotherapy (SBRT), or image-guided radiotherapy (IGRT) for millimeter-level accuracy.

China offers distinct advantages in radiation oncology: its top-tier hospitals—such as Peking University Cancer Hospital, Fudan University Shanghai Cancer Center, and Sun Yat-sen University Cancer Center—house state-of-the-art linear accelerators (including TrueBeam STx and Varian Halcyon systems), widely adopted proton therapy centers (e.g., Shanghai Proton and Heavy Ion Center), and multidisciplinary tumor boards with internationally trained radiation oncologists. Five-year local control rates for early-stage lung and head-and-neck cancers consistently meet or exceed global benchmarks. Crucially, treatment costs are typically 40–60% lower than in the US or Western Europe—without compromising protocol adherence or quality assurance standards. As your dedicated medical tourism partner, we streamline international access: verifying hospital accreditation, coordinating appointments with certified radiation oncologists, providing itemized, transparent pricing in advance, arranging visa support, translation services, and post-treatment follow-up—all tailored to ensure clinical continuity and peace of mind.

Treatment Options & Itemized Cost Breakdown: Radiation Oncology (Tumor Radiotherapy)

Non-Surgical/Conservative Options

*Indicated for localized, locally advanced, or palliative tumor control; requires confirmed histopathology and staging (CT/MRI/PET-CT).*

• •External Beam Radiotherapy (EBRT)

- Planning CT + contouring: $180–$220 - Daily treatment (per fraction): $75–$95 - Total course (25 fx): $1,875–$2,375 - Intensity-Modulated RT (IMRT) - For complex anatomy (e.g., head & neck, pelvis) requiring dose sculpting - Simulation + dosimetry planning: $420–$510 - Per-fraction delivery: $135–$165 - Total (28 fx): $3,780–$4,620 - Stereotactic Body RT (SBRT) - For oligometastatic or early-stage lung/liver/prostate tumors (1–5 fractions) - Motion management + image-guided setup: $680–$820 - Per-fraction: $290–$350 - Total (3 fx): $1,550–$1,870

• •Diagnostic & Monitoring Fees (per course)

- Weekly blood counts (CBC, LFTs): $25–$35/session × 5–6 sessions = $125–$210 - Acute toxicity management (medications, nursing): $320–$480

Surgical/Procedural/Interventional Options

*Eligibility: Histologically confirmed malignancy; adequate organ function (LVEF >50%, eGFR >60 mL/min); no uncontrolled systemic disease.*

• •Brachytherapy (High-Dose-Rate, HDR)

- Applicator insertion + imaging (US/CT): $450–$560 - Each HDR fraction (including afterloading): $210–$270 - Typical course (3–5 fx): $630–$1,350

• •Proton Beam Therapy

- Full-course simulation + beam modeling: $1,950–$2,380 - Per-fraction delivery: $380–$460 - Total (20–35 fx): $7,600–$16,100

• •Preoperative Workup (mandatory for brachytherapy/proton eligibility)

- Anesthesia consultation + lab panel (coagulation, electrolytes, renal/hepatic): $110–$170

Special/Complex Condition Options

• •Re-irradiation (same anatomical site): Requires prior RT records + dose reconstruction

- Fractionated course (10–15 fx): $2,200–$3,450

• •Total Body Irradiation (TBI) pre-transplant:

Quick Selection Guide

• •Elderly (>75 y), limited budget, metastatic disease: Standard EBRT ($1,875–$2,375) + palliative support
• •Young adult (<50 y), early-stage NSCLC or prostate cancer: SBRT ($1,550–$1,870) or IMRT ($3,780–$4,620) for maximal organ preservation
• •Comorbidities (COPD, CAD): Avoid proton therapy; select IMRT with respiratory gating (+ $220 planning fee)
• •Recurrence post-RT: Re-irradiation with strict dose constraints ($2,200–$3,450) + multidisciplinary review required
• •Pediatric solid tumor: Proton therapy ($7,600–$16,100) to minimize growth impairment and secondary malignancy risk